Darren Chong Long
About Darren Chong Long
Darren Chong Long is a Sr. Manager in New Product Planning at BeiGene in Shanghai, specializing in oncology and supporting business development in immunology and hematology.
Current Role at BeiGene
Darren Chong Long serves as the Sr. Manager for New Product Planning at BeiGene, based in Shanghai, China. He took on this role in November 2020. His responsibilities include supporting business development activities and pipeline strategy with a particular focus on oncology, including lung cancer, gastric cancer, and colorectal cancer. His work involves contributing to the advancement of immunology and hematology.
Experience at IQVIA Asia Pacific
From 2019 to 2020, Darren Chong Long served as a Management Consultant at IQVIA Asia Pacific in Singapore. During his one-year tenure, he was involved in various facets of strategic consulting within the healthcare and pharmaceutical industries, leveraging his expertise to provide tailored solutions and insights to clients.
Past Roles at AB Bernstein and Shimadzu
Darren Chong Long worked as a Summer Senior Equity Research Associate at AB Bernstein in Hong Kong for two months in 2018. Prior to that, he held a strategic position at Shimadzu (Asia Pacific) Pte Ltd in Singapore from 2014 to 2017. In this three-year period, he focused on managing strategic accounts across the Asia-Pacific region, enhancing the company's market presence and client relationships.
Previous Positions as Chemist and Trainee
Darren Chong Long's role as a Chemist at MSD spanned from 2013 to 2014 in Singapore, where he contributed to the company's chemistry operations. Before his stint at MSD, he was a trainee focusing on technical and marketing aspects of special fluids at Total for four months in 2013. Both roles provided him with valuable industry experience and technical knowledge.
Educational Background and Specializations
Darren Chong Long holds an MBA from INSEAD, obtained in 2018 after an 11-month program. He also studied at École Polytechnique in 2011 and completed an exchange program in Biochemistry at Arizona State University. His academic journey began at Nanyang Technological University in Singapore, where he earned a degree in Chemistry and Biological Chemistry from 2009 to 2013. His specialization in oncology includes a focus on lung cancer, gastric cancer, and colorectal cancer.